上药科园信海陕西医药有限公司

What 上药科园信海陕西医药有限公司 does

上药控股（陕西）有限公司 (the entity represented by 上药科园信海陕西医药有限公司 in source material) is a wholly-owned subsidiary of Shanghai Pharmaceuticals Group (上海医药集团, SSE: 601607, Fortune Global 500), founded in 2013 and headquartered in Xi'an, Shaanxi Province. It functions as a comprehensive pharmaceutical supply chain service provider in Shaanxi Province, operating across seven integrated modules: hospital direct sales (纯销), wholesale distribution (分销), OTC pharmacy distribution, medical devices and consumables, retail pharmacy, digital marketing services for manufacturers, and supply chain extension services (modern logistics, information systems, and omnichannel integration).

The company's distribution footprint spans the entirety of Shaanxi Province, reaching 3,000+ medical institutions, distributors, and OTC pharmacies. Its product portfolio comprises nearly 10,000 pharmaceutical SKUs spanning essential medicines, common generic drugs, scarce medications, emergency drugs, specialty drugs, and medical devices, of which 800+ are imported or joint-venture brands. Designated as the Shaanxi Province Scarcity Drug Reserve Base and certified compliant with the national Drug Cold Chain Logistics Standard, the company operates AAAA-class logistics infrastructure with cold chain capabilities and a fleet.

Revenue is generated through transaction-fee-style distribution across B2B channels (hospital direct sales, wholesale, OTC pharmacy, medical devices) plus professional services revenue from digital marketing and supply chain extension offerings to pharmaceutical manufacturers. Pricing is contractually negotiated and not publicly disclosed. The company is privately held as a subsidiary within the Shanghai Pharmaceuticals Group corporate structure, with no standalone funding rounds, M&A activity, or leadership transitions disclosed in the source materials.

Name

上药科园信海陕西医药有限公司

Legal name

上药控股（陕西）有限公司

Website

https://kyshaanxi.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Shanxi Province-based wholly-owned subsidiary of Shanghai Pharmaceuticals Group (SSE: 601607) providing comprehensive pharmaceutical distribution and supply chain services across hospital direct sales, wholesale, OTC, medical devices, retail, digital marketing, and logistics to 3,000+ medical institutions and partners.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)

akta.pro secondary industries

OTC Medicines & Consumer Health Products Distribution (CRAOAHAB), Pharmacy Logistics, Returns, Reverse Distribution & Compliance Services (CRAOAHAJ)

Keywords

• Pharmaceutical distribution
• Hospital direct sales
• Medical device supply
• Cold chain logistics
• Healthcare supply chain

Headquarters

HQ city

Xi'an

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Infrastructure, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Distribution: Distribution of pharmaceutical products including generic drugs, specialty drugs, scarce drugs, emergency medications, and medical devices to hospitals, clinics, distributors, and OTC pharmacies across Shaanxi Province.
2. Hospital Direct Sales: Direct sales of pharmaceutical products to medical institutions including essential medicines, common drugs, and imported合资 varieties.
3. OTC and Retail Distribution: Distribution to OTC pharmacies and retail outlets with nearly 10,000 product varieties including 800+ imported/international brand SKUs.
4. Digital Marketing Services: Digital marketing and supply chain extension services provided to pharmaceutical manufacturers for product distribution and market expansion.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels1 record

Core offering

上药科园信海陕西医药有限公司 (operating as 上药控股（陕西）有限公司) is a comprehensive pharmaceutical supply chain service provider in Shaanxi Province, distributing nearly 10,000 pharmaceutical and medical device product varieties (including 800+ imported and joint-venture SKUs) to more than 3,000 medical institutions, distributors, and OTC pharmacies across the province. Its core offerings span seven modules: hospital direct sales (纯销), wholesale distribution (分销), OTC pharmacy supply, medical device and consumables distribution, retail pharmacy services, digital marketing services for pharmaceutical manufacturers, and supply chain extension services built on modern logistics, information systems, and omnichannel integration with cold chain capabilities.

Product overview

上药控股（陕西）有限公司 is a comprehensive pharmaceutical supply chain service provider under Shanghai Pharmaceuticals Group. The company operates a multi-module service platform combining hospital direct sales (纯销), wholesale distribution (分销), OTC pharmacy services, medical devices and consumables, retail pharmacy, digital marketing, and supply chain extension services. The portfolio includes nearly 10,000 pharmaceutical product varieties with over 800 imported and joint-venture product specifications. The company serves over 3,000 medical institutions, distributors, and OTC pharmacies across Shaanxi province, offering integrated supply chain and innovative service solutions including modern logistics, information systems, and omnichannel integration.

Differentiator

Problem solved

Functional benefit

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Shanghai Pharmaceuticals Group (上海医药集团)flagshipStrategic or Co-development PartnerParent company and strategic anchor. Shanghai Pharmaceuticals Group is a Fortune Global 500 company providing corporate backing, brand recognition, strategic direction, and access to broader pharmaceutical supply chain resources and manufacturer partnerships.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Sinopharm Group: China's largest pharmaceutical distributor and wholesaler, operating national hospital direct-sales and wholesale distribution networks. Directly comparable in business model (hospital direct sales, wholesale, retail, OTC) and customer base (medical institutions, retail pharmacies), and competes head-to-head for provincial distribution contracts.
• China Meheco (China Meheco Group): State-affiliated pharmaceutical distributor and trader with hospital direct sales and international pharmaceutical trading operations. Comparable in distribution to medical institutions and in international/imported product sourcing, particularly for specialty and scarce drugs.
• Jointown Pharmaceutical Group: One of China's largest private pharmaceutical distributors with national reach spanning hospital, retail, OTC, and distribution channels. Comparable in integrated channel mix and product breadth, and is a leading competitor in lower-tier and provincial markets.
• China Resources Pharmaceutical Commercial Group: Major national pharmaceutical distributor under China Resources, with hospital direct sales and wholesale operations across multiple provinces. Comparable in multi-channel distribution, cold chain capabilities, and large institutional customer rosters.

Regional players

• Chongqing Tongli Medical Co., Ltd. Regional pharmaceutical distributor in southwestern China with hospital and retail distribution. Comparable as a peer in western China with similar institutional customer base, although it primarily serves Chongqing rather than Shaanxi.
• Nanjing Pharmaceutical Co., Ltd. Regional pharmaceutical distributor anchored in eastern China (Jiangsu) with hospital direct sales, wholesale, and retail pharmacy operations. Highly comparable in business model and channel mix, though operating in a different geography.
• Guangzhou Pharmaceuticals Corporation: Major southern-China pharmaceutical distributor (Guangdong) with hospital direct sales and OTC distribution. Comparable channel structure and pharmaceutical product breadth, but serves a different regional market.

Broad incumbents

• Shanghai Pharmaceuticals Holding: Parent company of the subject (SSE: 601607) and one of China's largest pharmaceutical groups with national distribution, retail, and manufacturing operations. Although it is the parent, it sets the strategic agenda and operating standards that this subsidiary executes against.
• China Resources Sanjiu Medical & Pharmaceutical: Major Chinese pharmaceutical manufacturer and distributor with national reach across OTC, prescription, and hospital channels. Comparable as a broad incumbent whose distribution arm overlaps with the subject's multi-channel structure.

Emerging players

• Yiling Wulin (Yiling Pharmaceutical Distribution Subsidiary): Affiliated with Yiling Pharmaceutical, this subsidiary handles distribution of branded Chinese and western medicines through hospital and retail channels. Comparable as a manufacturer-affiliated regional distributor, though smaller and more product-concentrated than the subject.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/%E4%B8%8A%E8%8D%AF%E7%A7%91%E5%9B%AD%E4%BF%A1%E6%B5%B7%E9%99%95%E8%A5%BF%E5%8C%BB%E8%8D%AF%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 上药科园信海陕西医药有限公司